Help your child manage fears, worries and anxiety through play.
Lumi Nova is a NICE recommended digital therapeutic mobile game that helps children aged 7-12 years self manage worries and build resilience.
Lumi Nova: Tales of Courage
A NICE recommended, evidence based digital therapeutic intervention (mobile game) to help children and young people manage difficulties with fears, worries or anxiety:
For 7-12 year olds
Provides Psycho-Education and Exposure Therapy
Embedded outcome measures
Built in safeguarding & accessibility features
Provides data to Authorised Professionals securely through the VitaMind Hub
Available on Android and iOS
Co-created with young people, guardians, teachers, clinicians, academics, game experts
Points of use:
Early support settings
Self referrals
Point of triaging
Waitlist management
As adjunct to specialist support
To prevent relapse
Lumi Nova does not require constant clinical supervision.
INSTRUCTIONS FOR USE
Lumi Nova: Tales of Courage is a NICE-recommended digital therapeutic for children aged 7–12 years. Through an intergalactic adventure game, it helps them manage difficulties with fears, worries or anxiety, providing a first-line treatment to build lasting self-management skills.
Lumi Nova is not intended to be used by:
Young people who do not have parental or carer supervision
Young people with severe anxiety, in crisis, experiencing suicidal thoughts, or at risk of self-harm without the support of a mental health professional
Young people with severe mental health symptoms or diagnosis, who are not supported by a mental health professional.
Neurodivergence and SEND
When using Lumi Nova to support neurodivergent children or those with special educational needs and disabilities (SEND) who have worries, it is advised to do so under the guidance of their guardian or mental health professional. Ensure necessary adjustments are made beforehand to accommodate their sensory needs.
How to get access
Lumi Nova is available at no cost to families in growing areas of the UK in partnership with the NHS.